Latest Articles
Immunotherapy plus chemotherapy approved for endometrial cancer - The Pharmaceutical Journal
Immunotherapy plus chemotherapy approved for endometrial cancer The Pharmaceutical Journal
Published: Aug. 7, 2025, 2:48 p.m.
NICE backs KEYTRUDA combination for advanced endometrial cancer - PharmaTimes
NICE backs KEYTRUDA combination for advanced endometrial cancer PharmaTimes
Published: Aug. 7, 2025, 9:15 a.m.
Ovum Launches with $1.7M Funding to Develop AI-Powered Women’s Health Platform - Femtech Insider
Ovum Launches with $1.7M Funding to Develop AI-Powered Women’s Health Platform Femtech Insider
Published: Aug. 7, 2025, 7:33 a.m.
Ovum Launches with $1.7m Funding to Develop AI-Powered Women’s Health Platform - Femtech Insider
Ovum Launches with $1.7m Funding to Develop AI-Powered Women’s Health Platform Femtech Insider
Published: Aug. 7, 2025, 7:08 a.m.
Will CleanSpark Inc. see short term momentum - Sector Rotation Strategy for Smart Traders - Newser
Will CleanSpark Inc. see short term momentum - Sector Rotation Strategy for Smart Traders Newser
Published: Aug. 7, 2025, 2:03 a.m.
Combining price and volume data for FIGS - High Conviction Stock Long-Term Summary - Newser
Combining price and volume data for FIGS - High Conviction Stock Long-Term Summary Newser
Published: Aug. 7, 2025, 1:09 a.m.
“Rusty Machete Pain”: Former NC worker files ADA lawsuit over period pain - wfmynews2.com
“Rusty Machete Pain”: Former NC worker files ADA lawsuit over period pain wfmynews2.com
Published: Aug. 6, 2025, 7:43 p.m.
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences The Globe and Mail
Published: Aug. 6, 2025, 1:11 p.m.
Kate's chosen path to single parenting, led by love, strength and determination - The Border Mail
Kate's chosen path to single parenting, led by love, strength and determination The Border Mail
Published: Aug. 6, 2025, 9:01 a.m.
NICE recommends Keytruda for endometrial cancer - The Pharma Letter
NICE recommends Keytruda for endometrial cancer The Pharma Letter
Published: Aug. 6, 2025, 6:49 a.m.
Link copied to clipboard!